All Articles

  Introduction Acute promyelocytic leukemia (APL), the M3 type of acute myeloid leukemia (AML), typically relies on all-trans retinoic acid (ATRA) as its primary treatment. While APL patients treated with

Introduction Recent research unveils that hepatic insulin resistance (IR) and steatosis in obesity have a strong association with endoplasmic reticulum (ER)-mitochondria miscommunication. Notably,

On May 22nd~24th 2024 (10:00~17:00), the 29th International Food Ingredients & Additives Exhibition and Conference (IFIA 2024) will be held in Tokyo International Exhibition Center (Tokyo Big Sight, Sou

On May 6th 2024, BONTAC and NADclinic Group signed a partnership cooperation agreement, formalizing their ambition to become deep strategic partners. Dr. Cheung (chief scientist and BONTAC founder), Mr. Shu (BO

Aging is an undeniable reality of life. It is a known fact that with increasing age, different body functions tend to decline. While we may not completely stop this decline, we can slow it down with pure NMN po

Introduction On May 16th, BONTAC NMN products officially pass the authentication of self-affrimed GRAS (SELF GRAS), signifying that BONTAC R&D strength and the quality of NMN raw materials have

Introduction In the presence of oxygen, tumors produce adenosine triphosphate (ATP) through glycolysis instead of mitochondrial oxidative phosphorylation, a phenomenon known as the “Warburg effect”. Aerobi

Introduction Age-related macular degeneration (AMD) has become one of the leading cause of low vision and even blindness in the elderly, especially in those above 50. In 2020, approximately 1.8 million people aged ove

Introduction Natural products, including single components or extracts of herbal medicines, have the features of good efficacy and low toxicity when used in tumor treatment. They have unique advantages in treating dis